396 related articles for article (PubMed ID: 9376621)
1. Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
Konturek JW; Dembiński A; Konturek SJ; Domschke W
J Physiol Pharmacol; 1997 Sep; 48(3):383-91. PubMed ID: 9376621
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
Konturek JW; Fischer H; Konturek PC; Huber V; Boknik P; Luess H; Neumann J; Brzozowski T; Schmitz W; Hahn EG; Domschke W; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):153-64. PubMed ID: 11321509
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin.
Konturek JW; Konturek SJ; Stachura J; Domschke W
Aliment Pharmacol Ther; 1998 Sep; 12(9):857-64. PubMed ID: 9768528
[TBL] [Abstract][Full Text] [Related]
4. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.
Konturek JW; Dembinski A; Konturek SJ; Stachura J; Domschke W
Gastroenterology; 1998 Feb; 114(2):245-55. PubMed ID: 9453483
[TBL] [Abstract][Full Text] [Related]
5. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase.
Konturek PC; Kania J; Hahn EG; Konturek JW
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():125-36. PubMed ID: 17218764
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
9. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
10. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
Lanza FL; Evans DG; Graham DY
Am J Gastroenterol; 1991 Jun; 86(6):735-7. PubMed ID: 2038996
[TBL] [Abstract][Full Text] [Related]
12. Gastric adaptation to aspirin and Helicobacter pylori infection in man.
Konturek J; Konturek S; Dembinski A; Domschke W
J Gastroenterol Hepatol; 1998 Nov; 13(S3):S193-S198. PubMed ID: 28976678
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of different methods applied for detecting Helicobacter pylori infection in gastric mucosa].
Korzonek M
Ann Acad Med Stetin; 1997; 43():143-59. PubMed ID: 9471913
[TBL] [Abstract][Full Text] [Related]
15. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
[TBL] [Abstract][Full Text] [Related]
16. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
18. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.
Thomson AB; Marshall JK; Hunt RH; Provenza JM; Lanza FL; Royer MG; Li Z; Blank MA;
J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894
[TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
Konturek PC; Kania J; Gessner U; Konturek SJ; Hahn EG; Konturek JW
Eur J Pharmacol; 2004 Dec; 506(2):169-77. PubMed ID: 15588738
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
Wex T; Kuester D; Vieth M; Treiber G; Krieg A; Roessner A; Malfertheiner P
Scand J Gastroenterol; 2008; 43(10):1194-201. PubMed ID: 18609127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
